Journal of Translational Medicine
2024 Jul 5;22(1):630.

Matthias Löhn & Klaus Josef Wirth

 Linda Elsegood interviewing Andrea, a patient from the United States who has been taking low dose naltrexone (LDN) to manage her health concerns.

Review  Open access  Published: 05 July 2024
Volume 22, article number 630, (2024)

Matthias Löhn & Klaus Josef Wirth

Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone

05 July 2024, Volume 22, article number 630, (2024)

Matthias Löhn and Klaus Josef Wirth

Journal of Translational Medicine 

Addiction Medication Offers New Hope for Long COVID Patients
Featured in Neurology Neuroscience·May 7, 2024

https://neurosciencenews.com/naltrexone-long-covid-26048/

New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
Medscape Medical News > Conference News
December 21, 2023

https://www.medscape.com/viewarticle/new-research-aims-unravel-both-me-cfs-and-long-covid-2023a1000w9b?form=fpf